Fountain Therapeutics
PrivateLast Round
Series B
Aug 13, 2025
Total Funding Raised
$44M
Company Overview
Fountain Therapeutics is a biotechnology company focused on developing therapeutics that aim to reverse cellular aging and treat age-related diseases through an innovative platform that integrates artificial intelligence and computer vision for identifying novel therapeutic targets.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fountain Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Fountain Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 13, 2025 | ||||
| Series A Extension | Nov 18, 2021 | ||||
| Series A Extension | May 19, 2020 | ||||
| Series A | May 7, 2018 |
Fountain Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Series A Extension |
| Nan Fung Life Sciences | Series A Extension, Series A |
| EOS Ventures | Series B |
| R42 Group | Series A Extension |
| Alexandria Venture Investments | Series A Extension |
Fountain Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fountain Therapeutics's valuation, stock price, and market status.
